Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126523) titled 'Efficacy and Survival Prognostic Analysis of Hypofractionated Intensity-Modulated Radiation Therapy for Refractory Brain Metastases' on June 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: BEIJING LUHE HOSPITAL CAPITAL MEDICAL UNIVERSITY
Condition:
Malignant tumor
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-11-07
Target Sample Size: Observation group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=320938
Published by HT Digital Content Services with permission from Health Daily Digest....